Evidence of estrone-sulfate uptake modification in young and middle-aged rat prostate

Journal of Steroid Biochemistry and Molecular Biology

Volumn 152, Issue , 2015, Pages 89-100

  Giton, Frank ^a,b   Sirab, Nanor ^b   Franck, Grégory ^c   Gervais, Marianne ^c   Schmidlin, Fabien ^d   Ali, Tauhid ^d   Allory, Yves ^a,b   Taille, Alexandre De La ^b   Vacherot, Francis ^b   Loric, Sylvain ^a,b   Fiet, Jean ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM U955   (France)

^c CNRS   (France)

^d IPSEN   (France)

Author keywords

Estrogens; Estrone sulfate; Organic anion transporting polypeptides; Pro inflammatory cytokines; Prostate cancer; Sulfatase inhibitor

Indexed keywords

ESTRONE SULFATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; IROSUSTAT; MESSENGER RNA; ORGANIC ANION TRANSPORTER B; ORGANIC ANION TRANSPORTER E; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A2; STERYL SULFATASE; TUMOR NECROSIS FACTOR ALPHA; ANTIPORTER; CONJUGATED ESTROGEN; CYTOKINE; ESTROGEN; ESTRONE; EYE PROTEIN; ORGANIC ANION TRANSPORTER; SLCO4A1 PROTEIN, RAT; SULFONIC ACID DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN BLOOD LEVEL; GENETIC STABILITY; HORMONAL THERAPY; MALE; MIDDLE AGED; NONHUMAN; PROSTATE; PROTEIN EXPRESSION; RAT; STEROID BLOOD LEVEL; TISSUE LEVEL; AGE; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL MODEL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLOOD; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL;

RATTUS;

AGE FACTORS; ANIMALS; ANTIPORTERS; BIOLOGICAL TRANSPORT; CYTOKINES; ESTROGENS; ESTROGENS, CONJUGATED (USP); ESTRONE; EYE PROTEINS; MALE; MODELS, ANIMAL; ORGANIC ANION TRANSPORTERS; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STERYL-SULFATASE; SULFONIC ACIDS;

EID: 84929207974     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.05.002     Document Type: Article

References (50)

1. C. Huggins, and C.V. Hodges Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate CA. Cancer J. Clin. 22 1972 232 240
2. G.P. Risbridger, J.J. Bianco, S.J. Ellem, and S.J. McPherson Oestrogens and prostate cancer Endocr.-Relat. Cancer 10 2003 187 191
3. E.G. Rogan, and E.L. Cavalieri Estrogen metabolites, conjugates, and DNA adducts: possible biomarkers for risk of breast, prostate, and other human cancers Adv. Clin. Chem. 38 2004 135 149
4. M.C. Bosland Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis Ann. NY Acad. Sci. 1089 2006 168 176
5. G. Carruba Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario J. Cell Biochem. 102 2007 899 911
6. Y. Nakamura, T. Suzuki, T. Fukuda, A. Ito, M. Endo, T. Moriya, Y. Arai, and H. Sasano Steroid sulfatase and estrogen sulfotransferase in human prostate cancer Prostate 66 2006 1005 1012
7. B.E. Henderson, and H.S. Feigelson Hormonal carcinogenesis Carcinogenesis 21 2000 427 433
8. J.M. Kaufman, and A. Vermeulen The decline of androgen levels in elderly men and its clinical and therapeutic implications Endocr. Rev. 26 2005 833 876
9. F. Giton, A. de la Taille, Y. Allory, H. Galons, F. Vacherot, P. Soyeux, C.C. Abbou, S. Loric, O. Cussenot, J.P. Raynaud, and J. Fiet Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa) J. Steroid Biochem. Mol. Biol. 109 2008 158 167
10. M.A. Joseph, J.T. Wei, S.D. Harlow, K.A. Cooney, R.L. Dunn, C.A. Jaffe, J.E. Montie, and D. Schottenfeld Relationship of serum sex-steroid hormones and prostate volume in African American men Prostate 53 2002 322 329
11. H.J. Im, N.H. Park, Y.J. Kwon, S. Shin, D. Kim, and Y.J. Chun Bacterial lipopolysaccharides induce steroid sulfatase expression and cell migration through IL-6 pathway in human prostate cancer cells Biomol. Ther. 20 2012 556 561
12. F. Labrie, V. Luu-The, A. Bélanger, S.X. Lin, J. Simard, G. Pelletier, and C. Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol. 187 2005 169 196
13. H. Klein, T. Molwitz, and W. Bartsch Steroid sulfate sulfatase in human benign prostatic hyperplasia: characterization and quantification of the enzyme in epithelium and stroma J. Steroid Biochem. Mol. Biol. 33 1989 195 200
14. H. Pressler, T.M. Sissung, D. Venzon, D.K. Price, and W.D. Figg Expression of OATP family members in hormone-related cancers: potential markers of progression PLoS One 6 2011 e20372
15. J.L. Wright, E.M. Kwon, E.A. Ostrander, R.B. Montgomery, D.W. Lin, R. Vessella, J.L. Stanford, and E.A. Mostaghel Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes Cancer Epidem. Biomar. 20 2011 619 627
16. M. Yang, W. Xie, E. Mostaghel, M. Nakabayashi, L. Werner, T. Sun, M. Pomerantz, M. Freedman, R. Ross, M. Regan, N. Sharifi, W.D. Figg, S. Balk, M. Brown, M.E. Taplin, W.K. Oh, G.S. Lee, and P.W. Kantoff SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer J. Clin. Oncol. 29 2011 2565 2573
17. A. Obaidat, M. Roth, and B. Hagenbuch The expression and function of organic anion transporting polypeptides in normal tissues and in cancer Annu. Rev. Pharmacol. Toxicol. 52 2012 135 151
18. G.T. MacLennan, R. Eisenberg, R.L. Fleshman, J.M. Taylor, P. Fu, M.I. Resnick, and S. Gupta The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study J. Urol. 176 3 2006 1012 1016
19. G.S. Palapattu, S. Sutcliffe, P.J. Bastian, E.A. Platz, A.M. De Marzo, W.B. Isaacs, and W.G. Nelson Prostate carcinogenesis and inflammation: emerging insights Carcinogenesis 26 7 2005 1170 1181
20. A.M. De Marzo, E.A. Platz, S. Sutcliffe, J. Xu, H. Grönberg, C.G. Drake, Y. Nakai, W.B. Isaacs, and W.G. Nelson Inflammation in prostate carcinogenesis Nat. Rev. Cancer 7 4 2007 256 269
21. M. Maggio, S. Basaria, G.P. Ceda, A. Ble, S.M. Ling, S. Bandinelli, G. Valenti, and L. Ferrucci The relationship between testosterone and molecular markers of inflammation in older men J. Endocrinol. Invest. 28 2005 116 119
22. M.J. Naslund, J.D. Strandberg, and D.S. Coffey The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis J. Urol. 140 1988 1049 1053
23. J. Bernoulli, E. Yatkin, Y. Konkol, E.M. Talvitie, R. Santti, and T. Streng Prostatic inflammation and obstructive voiding in the adult Noble rat: impact of the testosterone to estradiol ratio in serum Prostate 68 12 2008 1296 1306
24. H.A. Mosli, A.M. Al-Abd, M.A. El-Shaer, A. Khedr, F.S. Gazzaz, and A.B. Abdel-Naim Local inflammation influences oestrogen metabolism in prostatic tissue BJU Int. 110 2 2012 274 282
25. S.J. Ellem, H. Wang, M. Poutanen, and G.P. Risbridger Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy Am. J. Pathol. 175 2009 1187 1199
26. V. Ventura, J. Solà, C. Celma, C. Peraire, and R. Obach In vitro metabolism of irosustat, a novel steroid sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification Drug Metab. Dispos. 39 2011 1235 1246
27. S.J. Stanway, A. Purohit, L.W. Woo, S. Sufi, D. Vigushin, R. Ward, R.H. Wilson, F.Z. Stanczyk, N. Dobbs, E. Kulinskaya, M. Elliott, B.V. Potter, M.J. Reed, and R.C. Coombes Phase study of STX 64 (667Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor Clin. Cancer Res. 12 2006 1585 1592
28. P.A. Foster, L.W. Woo, B.V. Potter, M.J. Reed, and A. Purohit The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer Endocrinology 149 2008 4035 4042
29. F. Giton, P. Caron, R. Bérubé, A. Bélanger, O. Barbier, and J. Fiet Plasma estrone sulfate assay in men: comparison of radioimmunoassay, mass spectrometry coupled to gas chromatography (GC-MS), and liquid chromatography-tandem mass spectrometry (LC-MS/MS) Clin. Chim. Acta 411 2010 1208 1213
30. R.J. Handa, and M.J. Weiser Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis Front. Neuroendocrinol. 35 2014 197 220
31. E. Cavalieri, and E. Rogan Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture Ann. NY Acad. Sci. 1089 2006 286 301
32. A. Bélanger, B. Candas, A. Dupont, L. Cusan, P. Diamond, J.L. Gomez, and F. Labrie Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men J. Clin. Endocrinol. Metabol. 79 1994 1086 1090
33. P. Stattin, S. Rinaldi, C. Biessy, U.H. Stenman, G. Hallmans, and R. Kaaks High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort Stattin J. Clin. Oncol. 22 2004 3104 3112
34. E.A. Platz, M.F. Leitzmann, N. Rifai, P.W. Kantoff, Y.C. Chen, M.J. Stampfer, W.C. Willett, and E. Giovannucci Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era Cancer Epidem. Biomar. 14 2005 1262 1269
35. A.W. Roddam, N.E. Allen, P. Appleby, and T.J. Key Prostate cancer Collaborative Group Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies J. Nat. Cancer 100 2008 170 183 Inst
36. G.G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.A. Gustafsson Cloning of a novel receptor expressed in rat prostate and ovary Proc. Natl. Acad. Sci. U. S. A. 93 1996 5925 5930
37. E. Cavalieri, P. Devanesan, M.C. Bosland, A.F. Badawi, and E.G. Rogan Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer Carcinogenesis 23 2002 329 333
38. L. Feferman, S. Bhattacharyya, L. Birch, G.S. Prins, and J.K. Tobacman Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development J. Steroid Biochem. Mol. Biol. 143 2014 105 114
39. S.P. Newman, A. Purohit, M.W. Ghilchik, B.V.L. Potter, and M.J. Reed Regulation of steroid sulphatase expression and activity in breast cancer J. Steroid Biochem. Mol. Biol. 75 4-5 2000 259 264
40. H.E. Rosenthal, E. Pietrzak, W.R. Slaunwhite Jr, and A.A. Sandberg Binding of estrone sulfate in human plasma J. Clin. Endocrinol. Metab. 34 5 1972 805 813
41. L. Savu, G. Vallette, E.A. Nunez, and M.F. Jayle The binding of estrone sulfate by rat serum proteins during development Biochim. Biophys. Acta 328 2 1973 533 542
42. Bouhamidi R1, J.L. Gaillard, P. Silberzahn, and B. Martin Binding of estrogen-3-sulfates to stallion plasma and equine serum albumin J. Steroid Biochem. Mol. Biol. 42 3-4 1992 345 349
43. C. Le Goascogne, N. Sananès, M. Gouézou, S. Takemori, S. Kominami, E.E. Baulieu, and P. Robel Immunoreactive cytochrome P-450(17 alpha) in rat and guinea-pig gonads, adrenal glands and brain J. Reprod. Fertil. 93 1991 609 622
44. B.A. Keel Effects of aging on biologically active pituitary LH in rats Arch. Androl. 20 1988 203 209
45. S. Fujita, M. Chiba, M. Ohta, K. Kitani, and T. Suzuki Alteration of plasma sex hormone levels associated with old age and its effect on hepatic drug metabolism in rats J. Pharmacol. Exp. Ther. 253 1990 369 374
46. K. Wright, D.C. Collins, P.I. Musey, and J.R. Preedy A specific radioimmunoassay for estrone sulfate in plasma and urine without hydrolysis J. Clin. Endocrol. Metabol. 47 1978 1092 1098
47. F. Labrie Intracrinology Mol. Cell Endocrinol. 78 1991 C113 C118
48. M. Krieg, H. Weisser, and S. Tunn Potential activities of androgen metabolizing enzymes in human prostate J. Steroid Biochem. Mol. Biol. 53 1995 395 400
49. M. Grube, K. Köck, S. Karner, S. Reuther, C.A. Ritter, G. Jedlitschky, and H.K. Kroemer Modification of OATP2B1-mediated transport by steroid hormones Mol. Pharmacol. 70 2006 1735 1741
50. P. Stute, A. Reichenbach, T. Szuwart, L. Kiesel, and M. Götte Impact of testosterone on the expression of organic anion transporting polypeptides (OATP-1A2, OATP-2B1, OATP-3A1) in malignant and non-malignant human breast cells in vitro Maturitas 71 2012 376 384